← Back to home
Comparison · Analytics

ApexCharts vs glyenzy

A side-by-side editorial comparison of ApexCharts and glyenzy — release velocity, themes, recent moves, and the top alternatives to consider.

ApexCharts vs glyenzy: at a glance

FeatureApexChartsglyenzy
SectorAnalyticsAnalytics
Velocity score10.06.3
Sparks · 30d31
Top themescharting, raw-data-input, chart-morphing, premium-tieringglycomics, biosynthesis, enzyme-inference, network-analysis
Last editorial update1d ago2d ago
WebsiteVisit →Visit →

What is ApexCharts?

Licensing settled, ApexCharts is back to changing what a chart can take as input.

ApexCharts is deep into a fast v6 line, shipping roughly weekly. The licensing arc that dominated 6.5 through 6.7 — trial watermarks, the first premium-gated chart type, then entitlement checks — has settled, and the last three releases are library work again. 6.9.0 is the largest of them: a histogram type that bins raw samples, a morph engine that conserves marks across chart types, and the end of the library's dependency-free packaging.

Read the full ApexCharts trajectory →

What is glyenzy?

Glycan biosynthesis as a traceable enzyme graph, now including sulfation and gaps it can bridge.

glyenzy infers which enzymes could have produced a glycan and traces biosynthetic routes to it, backed by curated per-enzyme rules for human glycosyltransferases and, since 0.7.0, twelve sulfotransferases. Biosynthesis functions return typed network objects that keep their igraph interface while supporting layered DAG plots with glycan nodes and labelled enzyme edges. Where no concrete enzyme covers a step, bounded virtual transitions bridge the gap and are marked so users can see which edges are inferred rather than enzymatic.

Read the full glyenzy trajectory →

ApexCharts vs glyenzy: editorial side-by-side

A
ApexCharts
ANALYTICS
10.0

Licensing settled, ApexCharts is back to changing what a chart can take as input.

◆ Current state

ApexCharts is deep into a fast v6 line, shipping roughly weekly. The licensing arc that dominated 6.5 through 6.7 — trial watermarks, the first premium-gated chart type, then entitlement checks — has settled, and the last three releases are library work again. 6.9.0 is the largest of them: a histogram type that bins raw samples, a morph engine that conserves marks across chart types, and the end of the library's dependency-free packaging.

◆ Where it's heading

The through-line now is input and arrangement rather than catalogue size. Charts increasingly accept the measurements a team actually has instead of pre-aggregated values, and the seams that let you hand a chart its own layout — plotOptions.unit.positions, the pluggable layout hook — are being filled in with kits rather than hard-coded options. The premium boundary has stopped moving; the free catalogue keeps growing around it.

◆ Prediction

Expect the raw-observation pattern to reach another chart type now that the bar pathway handles binning, and expect the remaining pluggable seams to get companion kits the way positions just did.

G
glyenzy
ANALYTICS
6.3

Glycan biosynthesis as a traceable enzyme graph, now including sulfation and gaps it can bridge.

◆ Current state

glyenzy infers which enzymes could have produced a glycan and traces biosynthetic routes to it, backed by curated per-enzyme rules for human glycosyltransferases and, since 0.7.0, twelve sulfotransferases. Biosynthesis functions return typed network objects that keep their igraph interface while supporting layered DAG plots with glycan nodes and labelled enzyme edges. Where no concrete enzyme covers a step, bounded virtual transitions bridge the gap and are marked so users can see which edges are inferred rather than enzymatic.

◆ Where it's heading

Two kinds of release alternate here. One is enzyme curation, a steady stream of rule corrections for the FUT, MAN1A and MGAT families and removals where an enzyme turned out to act only on glycolipids, which is the unglamorous accuracy work a rule-based inference engine lives on. The other is turning biosynthesis output into a first-class object: paths became networks, networks became typed with plotting support, and targets became a marked vertex attribute. The package moves in lockstep with its siblings, pinning glyrepr 0.13.0 and glymotif 0.17.0 as those refreshed their data and matching APIs, and the latest release already speaks glydraw 0.8.0's orientation values.

◆ Prediction

The paucimannose N-glycan support dropped in 0.7.0 is the obvious loose end, with users told to stay on 0.6.3, so a reinstated implementation is a plausible next move. Beyond that the virtual-step machinery is new enough that its heuristics, particularly the inferred step limits added in 0.8.1, should keep being tuned.

Alternatives to ApexCharts and glyenzy

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either ApexCharts or glyenzy.

See all ApexCharts alternatives → · See all glyenzy alternatives →

Recent activity from ApexCharts and glyenzy

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 1d agoApexChartsUnit charts get a 39-shape companion kit
  2. 2d agoApexChartsHistogram bins raw samples; charts morph between types
  3. 9d agoApexChartsPer-data-point label offsets land as functions
  4. 10d agoApexChartsPie and donut slice clicks work again after a 6.7.0 regression
  5. 16d agoglyenzyStep limits inferred from the target glycan; MGAT4 and MGAT5 rules updated
  6. 16d agoApexChartsSunburst charts arrive; premium features now need an entitled plan
  7. 20d agoglyenzyBiosynthesis results become typed network objects with layered DAG plots
  8. 22d agoApexChartsUnit chart is the first premium-gated chart type
  9. 26d agoglyenzySulfotransferases become first-class, and unsupported steps can be bridged
  10. 1mo agoglyenzyCompatibility with glymotif 0.17.0 and later
  11. 1mo agoglyenzyEnzyme data refreshed against glyrepr 0.13.0 structure data
  12. 2mo agoglyenzyCorrected rules for the MAN1A1, MAN1A2 and MAN1C1 mannosidases

Frequently asked questions

What is the difference between ApexCharts and glyenzy?

They serve adjacent needs but don't currently overlap on shipped themes. ApexCharts is currently shipping more aggressively (velocity 10.0 vs 6.3), with 3 editorial sparks in the last 30 days against 1. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is ApexCharts better than glyenzy?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. ApexCharts is currently shipping more aggressively (velocity 10.0 vs 6.3), with 3 editorial sparks in the last 30 days against 1. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to ApexCharts?

Top ApexCharts alternatives in Analytics are ranked by recent ship velocity. Browse the "ApexCharts alternatives" section above for the current picks, or visit /alternatives/apexcharts for the full list with editorial commentary on each.

What are the best alternatives to glyenzy?

Top glyenzy alternatives in Analytics are ranked by recent ship velocity. Browse the "glyenzy alternatives" section above for the current picks, or visit /alternatives/glyenzy for the full list with editorial commentary on each.